Bristol Myers Squibb (BMY) Enterprise Value (2009 - 2026)
Bristol Myers Squibb (BMY) reported Enterprise Value of -$10.5 billion for Q1 2026, up 10.84% year-over-year from -$9.4 billion in Q1 2025, and up 1.77% on a QoQ basis from -$10.6 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Enterprise Value data on file, last reported at -$10.5 billion in Q1 2026.
- Quarterly Enterprise Value rose 10.84% year-over-year to -$10.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.5 billion (up 10.84% YoY) and the FY2025 annual result came in at -$10.6 billion, up 1.54% from the prior year.
- Enterprise Value climbed to -$10.5 billion in Q1 2026 per BMY's latest filing, from -$10.6 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$6.6 billion in Q2 2024 and bottomed at -$16.5 billion in Q3 2025.
- The 5-year median for Enterprise Value is -$10.5 billion (2026), against an average of -$10.7 billion.
- The widest annual swing landed in 2022, when Enterprise Value jumped 45.61%; it then tumbled 105.32% in 2025.
- Tracing BMY's Enterprise Value over 5 years: stood at -$9.2 billion in 2022, then plunged by 32.94% to -$12.2 billion in 2023, then climbed by 11.61% to -$10.8 billion in 2024, then rose by 1.54% to -$10.6 billion in 2025, then advanced by 1.77% to -$10.5 billion in 2026.
- Per Business Quant, the three latest BMY Enterprise Value figures stand at -$10.5 billion (Q1 2026), -$10.6 billion (Q4 2025), and -$16.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -9.35 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -5.65 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -7.73 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.77 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -10.45 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | -4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.45 Bn |
| Dec 31, 2025 | -10.64 Bn |
| Sep 30, 2025 | -16.45 Bn |
| Jun 30, 2025 | -13.55 Bn |
| Mar 31, 2025 | -11.72 Bn |
| Dec 31, 2024 | -10.81 Bn |
| Sep 30, 2024 | -8.04 Bn |
| Jun 30, 2024 | -6.60 Bn |
| Mar 31, 2024 | -9.61 Bn |
| Dec 31, 2023 | -12.23 Bn |
| Sep 30, 2023 | -7.62 Bn |
| Jun 30, 2023 | -8.67 Bn |
| Mar 31, 2023 | -9.21 Bn |
| Dec 31, 2022 | -9.20 Bn |
| Sep 30, 2022 | -8.96 Bn |
| Jun 30, 2022 | -13.17 Bn |
| Mar 31, 2022 | -14.90 Bn |
| Dec 31, 2021 | -16.91 Bn |
| Sep 30, 2021 | -15.59 Bn |
| Jun 30, 2021 | -12.90 Bn |
| Mar 31, 2021 | -12.86 Bn |
| Dec 31, 2020 | -15.77 Bn |
| Sep 30, 2020 | -21.08 Bn |
| Jun 30, 2020 | -21.59 Bn |
| Mar 31, 2020 | -18.26 Bn |
| Dec 31, 2019 | -15.29 Bn |
| Sep 30, 2019 | -32.44 Bn |
| Jun 30, 2019 | -29.26 Bn |
| Mar 31, 2019 | -8.67 Bn |
| Dec 31, 2018 | -8.66 Bn |
| Sep 30, 2018 | -6.72 Bn |
| Jun 30, 2018 | -5.97 Bn |
| Mar 31, 2018 | -6.66 Bn |
| Dec 31, 2017 | -10.73 Bn |
| Sep 30, 2017 | -6.99 Bn |
| Jun 30, 2017 | -6.38 Bn |
| Mar 31, 2017 | -5.99 Bn |
| Dec 31, 2016 | -6.18 Bn |
| Sep 30, 2016 | -5.39 Bn |
| Jun 30, 2016 | -4.49 Bn |
| Mar 31, 2016 | -4.14 Bn |
| Dec 31, 2015 | -4.11 Bn |
| Sep 30, 2015 | -5.22 Bn |
| Jun 30, 2015 | -5.31 Bn |
| Mar 31, 2015 | -7.46 Bn |
| Dec 31, 2014 | -7.30 Bn |
| Sep 30, 2014 | -7.16 Bn |
| Jun 30, 2014 | -7.12 Bn |
| Mar 31, 2014 | -7.00 Bn |
| Dec 31, 2013 | -4.44 Bn |
| Sep 30, 2013 | -2.73 Bn |
| Jun 30, 2013 | -2.80 Bn |
| Mar 31, 2013 | -2.49 Bn |
| Dec 31, 2012 | -2.81 Bn |
| Sep 30, 2012 | -2.93 Bn |
| Jun 30, 2012 | -5.32 Bn |
| Mar 31, 2012 | -5.12 Bn |
| Dec 31, 2011 | -8.82 Bn |
| Sep 30, 2011 | -8.33 Bn |
| Jun 30, 2011 | -7.88 Bn |
| Mar 31, 2011 | -6.89 Bn |
| Dec 31, 2010 | -7.38 Bn |
| Sep 30, 2010 | -11.40 Bn |
| Jun 30, 2010 | -9.60 Bn |
| Mar 31, 2010 | -8.03 Bn |
| Dec 31, 2009 | -8.57 Bn |
| Sep 30, 2009 | -8.83 Bn |
| Jun 30, 2009 | -9.58 Bn |
| Mar 31, 2009 | -870.00 Mn |